M2e universal influenza vaccine (VaxInnate)

N/A

Report date: 2022/07/19 16:22:54

Base Information

Drug NameM2e universal influenza vaccine (VaxInnate)

Drug Alias NameM2e通用流感疫苗 - VaxInnateFlagellin.HuM2eM2e-FlagellinSTF2.4xM2eVAX-102

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Biological material > Viral vaccine

Mechanisms of ActionImmunostimulantsToll-like receptor agonists

TargetsToll-like receptor

Therapy Area/IndicationsInfluenza, Human

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesVaxinnate

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesVaxinnate Co

Active IndicationsN/A

Inactive IndicationsInfluenza, Human

Other Information

ATC CodeN/A